Outros (116)

¹ Publicaciones consideradas como producción de la unidad.

Ver datos de investigación referenciados.

filter_list Tipo (agr.) Outros

2025

  1. Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial(Nature Medicine, 10.1038/s41591-023-02347-y)

    Nature Medicine

  2. Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy (Nature, (2019), 569, 7756, (428-432), 10.1038/s41586-019-1162-y)

    Nature

  3. Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease

    The journal of prevention of Alzheimer's disease

  4. Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Cancer Discovery

  5. Embracing the Modern Biochemistry of Brain Metabolism

    Journal of Neurochemistry

  6. Erratum: Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders (Journal of clinical immunology (2024) 45 1 DOI: 10.1007/s10875-024-01818-2.)

    Journal of clinical immunology

  7. Reading Between the Lines: Circulating Tumor DNA Dynamics Illuminate Immunotherapy Outcomes in Lung Squamous Cell Carcinoma

    Journal of Thoracic Oncology

2024

  1. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  2. Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report

    Journal of Neurology

  3. Espectrometría de masas en los laboratorios clínicos de proteínas

    Advances in Laboratory Medicine

  4. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

    Translational Neurodegeneration

  5. Mass spectrometry in clinical protein laboratories

    Advances in Laboratory Medicine

  6. Oncolytic adenoviruses and immunopeptidomics: a convenient marriage

    Molecular Oncology

  7. Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S

    European Journal of Neurology

2023

  1. Editorial: New insights into the role of neuroinflammation and glial cells in the development of neurological disorders

    Frontiers in Cellular Neuroscience

  2. Hemihypomimia in Parkinson’s disease: an under-recognized clinical sign?

    Journal of Neurology

  3. Inequity of access to new migraine treatments

    Neurologia

2022

  1. Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial

    Brain Stimulation

  2. Preoperative Hemoglobin and Actual Need for Blood Transfusion in Brain Tumor Resection Procedures: A Retrospective Cohort Study

    Journal of Neurosurgical Anesthesiology

2021

  1. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation (Scientific Reports, (2019), 9, 1, (14172), 10.1038/s41598-019-50627-w)

    Scientific Reports